Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Fractyl Health Inc (NASDAQ: GUTS) was $2.0 for the day, down -2.91% from the previous closing price of $2.06. In other words, the price has decreased by -$2.91 from its previous closing price. On the day, 4.34 million shares were traded. GUTS stock price reached its highest trading level at $2.06 during the session, while it also had its lowest trading level at $1.95.
Ratios:
Our analysis of GUTS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.27 and its Current Ratio is at 4.27.
Upgrades & Downgrades
In the most recent recommendation for this company, H.C. Wainwright on September 15, 2025, initiated with a Buy rating and assigned the stock a target price of $9.
On August 28, 2025, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $3.60.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 04 ’25 when Rajagopalan Harith bought 10,416 shares for $1.92 per share. The transaction valued at 19,999 led to the insider holds 501,745 shares of the business.
Royan Ajay bought 17,901 shares of GUTS for $22,980 on Mar 14 ’25. The Director now owns 17,901 shares after completing the transaction at $1.28 per share. On Mar 14 ’25, another insider, Barnes Kelly Ann, who serves as the Director of the company, bought 31,000 shares for $1.30 each. As a result, the insider paid 40,210 and bolstered with 31,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GUTS now has a Market Capitalization of 306744096 and an Enterprise Value of 259301104. Its current Enterprise Value per Revenue stands at 86433.7 whereas that against EBITDA is -2.655.
Stock Price History:
The Beta on a monthly basis for GUTS is 1.63, which has changed by 0.084210515 over the last 52 weeks, in comparison to a change of 0.16623151 over the same period for the S&P500. Over the past 52 weeks, GUTS has reached a high of $3.03, while it has fallen to a 52-week low of $0.82. The 50-Day Moving Average of the stock is 16.62%, while the 200-Day Moving Average is calculated to be 32.78%.
Shares Statistics:
GUTS traded an average of 2.90M shares per day over the past three months and 2536490 shares per day over the past ten days. A total of 132.22M shares are outstanding, with a floating share count of 113.53M. Insiders hold about 17.16% of the company’s shares, while institutions hold 57.63% stake in the company. Shares short for GUTS as of 1765756800 were 9589100 with a Short Ratio of 3.31, compared to 1763078400 on 7135839. Therefore, it implies a Short% of Shares Outstanding of 9589100 and a Short% of Float of 8.140001.
Earnings Estimates
The dynamic stock of Fractyl Health Inc (GUTS) is currently being evaluated by a team of 5.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.17 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$1.31 and -$1.93 for the fiscal current year, implying an average EPS of -$1.63. EPS for the following year is -$0.7, with 5.0 analysts recommending between -$0.61 and -$0.88.
